Asthma News and Research

RSS

Asthma is a common inflammatory disease affecting the airways that leads to shortness of breath, coughing and wheezing. Symptoms range from mild to severe but are generally manageable with appropriate treatment.

US FDA grants tentative approval for LPI's Memantine HCl tablets

Lupin Pharmaceuticals, Inc. (LPI) announced today that it has received tentative approval from the US Food and Drug Administration (US FDA) for its Memantine Hydrochloride tablets, 5mg and 10mg.

21 Jan 2010

ABC publishes Pycnogenol monograph

The nonprofit American Botanical Council (ABC) has just published a monograph summarizing selected scientific and clinical studies of Pycnogenol®, a patented dietary ingredient from French maritime pine bark.

21 Jan 2010

Study identifies new mechanism that causes allergic response in people

WHAT: A new study in human cells has singled out a molecule that specifically directs immune cells to develop the capability to produce an allergic response. The signaling molecule, called thymic stromal lymphopoietin (TSLP), is key to the development of allergic diseases such as asthma, atopic dermatitis (eczema) and food allergy.

21 Jan 2010

Lupin's Mandideep facility receives FDA clearance

Pharma major, Lupin Ltd announced today that it has received official communication from the US FDA on the satisfactory resolution of the Warning Letter issued earlier to its Mandideep site. The company had received a Warning letter for its Mandideep site in May 2009. In the ensuing seven months, the company made significant enhancements and took appropriate corrective actions.

21 Jan 2010

Intelligent panic disorder treatment by using biofeedback analysis and web technologies

An online treatment system for patients suffering with panic disorder and anxiety problems combine biofeedback therapy with web technologies and allows patients and medical professionals to communicate effectively, according to research published in the International Journal of Business Intelligence and Data Mining.

20 Jan 2010

Motivational interviewing may help people to quit smoking

Addressing tobacco use without judging the user appears to help people quit, especially if a primary care physician uses a form of supportive counseling called "motivational interviewing," according to a new review of studies.

20 Jan 2010

New analysis reveals high rates of CNS disorders in autistic children

Nearly two-thirds of the children with Autistic Spectrum Disorders recorded in the National Birth Defect Registry (NBDR) also suffer from structural birth defects, according the national nonprofit, Birth Defect Research for Children (BDRC).

20 Jan 2010

New type of fat-producing cells may speed up treatments for muscular dystrophy and fibrosis

A team of University of British Columbia researchers has identified fat-producing cells that possess "dual-personalities" and may further the development of treatments for muscle diseases such as muscular dystrophy and fibrosis.

19 Jan 2010

Allergan to jointly promote its adjustable gastric band for bariatric surgery with Covidien

Covidien, a leading global provider of healthcare products, today announced the extension of its agreement with Allergan, Inc. to jointly promote Allergan’s LAP-BAND® System, the top-selling adjustable gastric band for bariatric surgery, in the United States.

18 Jan 2010

Repeal of Texas helmet law results in increased motorcycle fatalities

In Texas, the repeal of a motorcycle helmet law has been followed by a sharp increase in fatal motorcycle crashes, according to a study in the January Southern Medical Journal, official journal of the Southern Medical Association.

18 Jan 2010

University of Leicester study provides new insights into preventer and reliever treatments for asthma

A new study at the University of Leicester is probing why asthma relief inhalers might actually make asthma worse- and what can be done about it.

13 Jan 2010

Pathway Genomics launches new campaign to highlight the benefits of genetic testing services

Pathway Genomics™ (www.PATHWAY.com), a privately held, venture-backed company, today launched a new campaign designed to facilitate discussions around consumer genetic testing services. Called ‘DNA Conversation Starters,’ Pathway will address a range of topics about genetic testing, further educating members of the media, the genetic testing community, and consumers about the benefits of genetic testing services and the depth of information obtained from Pathway’s Genetic Health and Ancestry tests.

13 Jan 2010

Positive results from Asthmatx's AIR2 Trial published in AJRCCM

Asthmatx Inc., developer of bronchial thermoplasty with the Alair® System, announced today the publication of positive results from its pivotal study, the Asthma Intervention Research 2 (AIR2) Trial, in the American Journal of Respiratory and Critical Care Medicine (AJRCCM).

13 Jan 2010

3D structure of PI3Kdelta: An important drug target for a wide range of diseases

Intellikine announced today the publication of an article entitled, "The p110delta structure: mechanisms for selectivity and potency of new PI(3)K inhibitors," now available as an advanced online publication at Nature Chemical Biology.

12 Jan 2010

Ongoing pressures of human evolution could explain rise in disorders; scientists call for broader perspective

The subtle but ongoing pressures of human evolution could explain the seeming rise of disorders such as autism, autoimmune diseases, and reproductive cancers, researchers write in the Proceedings of the National Academy of Sciences.

12 Jan 2010

CVS/pharmacy and MinuteClinic urge Americans to protect themselves with H1N1 vaccine

CVS/pharmacy, the nation's leading retail pharmacy and MinuteClinic, the largest retail health care provider in the U.S., is urging more Americans to protect themselves and their families with an H1N1 vaccine during National Influenza Vaccination Week (January 10-16) as designated by U.S. Department of Health and Human Services Secretary Kathleen Sebelius and the Centers for Disease Control and Prevention (CDC).

12 Jan 2010

NicOx, TOPIGEN Pharmaceuticals terminate TPI 1020 collaboration

NicOx S.A. today announced that NicOx and TOPIGEN Pharmaceuticals Inc. have mutually terminated their collaboration for TPI 1020. This decision was made as a result of the acquisition of TOPIGEN by Pharmaxis announced yesterday.

12 Jan 2010

American Lung Association supports CDC's NIVW to highlight the importance influenza vaccination

The American Lung Association supports the Centers for Disease Control and Prevention's (CDC) National Influenza Vaccination Week (NIVW), January 10-16, 2010, which highlights the importance of annual influenza vaccination after the holiday season into January and beyond.

12 Jan 2010

Study demonstrates benefits of allergen immunotherapy for children with allergic rhinitis

Allergy immunotherapy, generally referred to as allergy vaccinations or shots, reduce total health care costs in children with allergic rhinitis (hay fever) by one-third, and prescription costs by 16 percent, according to a study published this month in Annals of Allergy, Asthma & Immunology, the scientific journal of the American College of Allergy, Asthma and Immunology (ACAAI).

11 Jan 2010

KaloBios Pharmaceuticals, Sanofi Pasteur partner in development of KB001 biologic for Pa infections

KaloBios Pharmaceuticals, Inc. today announced an agreement with Sanofi Pasteur, the vaccines division of the sanofi-aventis Group, for the development and commercialization of KB001, an investigational new biologic for the treatment or prevention of Pseudomonas aeruginosa (Pa) infections. Sanofi Pasteur will be responsible for the development and commercialization of KB001 and initially focus on hospital indications, including the prevention of Pa pneumonias in mechanically ventilated patients.

11 Jan 2010

Asthma News and Research

Further Reading

US FDA grants tentative approval for LPI's Memantine HCl tablets

ABC publishes Pycnogenol monograph

Study identifies new mechanism that causes allergic response in people

Lupin's Mandideep facility receives FDA clearance

Intelligent panic disorder treatment by using biofeedback analysis and web technologies

Motivational interviewing may help people to quit smoking

New analysis reveals high rates of CNS disorders in autistic children

New type of fat-producing cells may speed up treatments for muscular dystrophy and fibrosis

Allergan to jointly promote its adjustable gastric band for bariatric surgery with Covidien

Repeal of Texas helmet law results in increased motorcycle fatalities

University of Leicester study provides new insights into preventer and reliever treatments for asthma

Pathway Genomics launches new campaign to highlight the benefits of genetic testing services

Positive results from Asthmatx's AIR2 Trial published in AJRCCM

3D structure of PI3Kdelta: An important drug target for a wide range of diseases

Ongoing pressures of human evolution could explain rise in disorders; scientists call for broader perspective

CVS/pharmacy and MinuteClinic urge Americans to protect themselves with H1N1 vaccine

NicOx, TOPIGEN Pharmaceuticals terminate TPI 1020 collaboration

American Lung Association supports CDC's NIVW to highlight the importance influenza vaccination

Study demonstrates benefits of allergen immunotherapy for children with allergic rhinitis

KaloBios Pharmaceuticals, Sanofi Pasteur partner in development of KB001 biologic for Pa infections

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News